The Whole Exome Sequencing (WES) market is witnessing rapid transformation as genomic technologies become increasingly central to disease diagnosis, research, and personalized medicine. Whole exome sequencing analyzes the protein-coding regions of the genome, enabling accurate identification of disease-causing mutations and supporting targeted treatment approaches. The Whole Exome Sequencing...